Finally, survival analysis, based on clinical information from the TCGA-liver cancer datasets, revealed that the high expression of EZH2, GINS1, and TPX2 correlated positively with higher risk, CENPF and BUB1B were quite the contrary (Figure 6). The gene discussed is EZH2; the disease is liver cancer.